NCT00365911

Brief Summary

Blood sample is taken for measurement of serum creatinine, cystatin C, clone V haemoglobin, cholesterol, urine acid, glycemia and CRP. The medical file is gathered. There will be searched for an association between renal function and cardiovascular risk factors and risk factors by exposition to toxic substantia during work.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for not_applicable healthy

Timeline
Completed

Started Mar 2006

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2006

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 17, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 18, 2006

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2009

Completed
Last Updated

June 2, 2011

Status Verified

June 1, 2011

Enrollment Period

3.8 years

First QC Date

August 17, 2006

Last Update Submit

June 1, 2011

Conditions

Healthy

Keywords

No specific condition

Outcome Measures

Primary Outcomes (1)

  • A possible association between renal clearance and found cardiovascular risk factors and risk factors by exposition to toxic substantia during work.

    At time T0

Interventions

Taking blood samplePROCEDURE

A blood sample will be taken.

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years
  • Male and female subjects

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Ghent

Ghent, 9000, Belgium

Location

Related Publications (1)

  • van der Tol A, Van Biesen W, Verbeke F, De Groote G, Vermeiren F, Eeckhaut K, Vanholder R. Towards a rational screening strategy for albuminuria: results from the unreferred renal insufficiency trial. PLoS One. 2010 Oct 13;5(10):e13328. doi: 10.1371/journal.pone.0013328.

    PMID: 20967254DERIVED

Related Links

MeSH Terms

Interventions

Blood Specimen Collection

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Raymond Vanholder, MD, PhD

    University Hospital, Ghent

    PRINCIPAL INVESTIGATOR

  • Wim Van Biesen, MD, PhD

    University Hospital, Ghent

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 17, 2006

First Posted

August 18, 2006

Study Start

March 1, 2006

Primary Completion

December 1, 2009

Study Completion

December 1, 2009

Last Updated

June 2, 2011

Record last verified: 2011-06

Locations

BE(1)